Critically ill men in drug trial continue to improveBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7544.746-a (Published 30 March 2006) Cite this as: BMJ 2006;332:746
- Susan Mayor
One of the two men left critically ill by a phase I trial of a new monoclonal antibody almost two weeks ago is improving, says the latest statement released by the hospital caring for him.
The statement, from the critical care department at Northwick Park Hospital, London, said, “The two volunteers have each made improvements since last week. One is in a serious condition. The other is still critical …